Skip to main content
Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China flag China · Delayed Price · Currency is CNY
81.45
+0.74 (0.92%)
Apr 29, 2026, 4:00 PM EDT

SHE:301075 Revenue

In the year 2025, Tibet Duo Rui Pharmaceutical had annual revenue of 154.18M CNY, down -35.93%. Tibet Duo Rui Pharmaceutical had revenue of 17.18M in the quarter ending December 31, 2025, a decrease of -57.17%.

Revenue
154.18M
Revenue Growth
-46.57%
P/S Ratio
41.71
Revenue / Employee
310.21K
Employees
497
Market Cap
6.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025154.18M-86.45M-35.93%
Dec 31, 2024240.63M-93.67M-28.02%
Dec 31, 2023334.30M-66.75M-16.64%
Jan 1, 2023401.05M-128.57M-24.28%
Jan 1, 2022529.62M39.45M8.05%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Beijing Sun-Novo Pharmaceutical Research 1.19B
Hainan Haiyao 831.18M
Hunan Jiudian Pharmaceutical 3.01B
Heilongjiang ZBD Pharmaceutical 1.59B
Shandong Wit Dyne Health 2.02B
ChengDa Pharmaceuticals 406.37M
Jinghua Pharmaceutical Group 1.46B
Guizhou Xinbang Pharmaceutical 5.62B
Revenue Rankings